The analysis also reported that baseline concentrations of CRP (6.0 mg/L vs. 4.2 mg/L; p < 0.0001) and IL-6 (3.2 vs. 2.6 ng/L; p < 0.0001) were significantly higher among participants subsequently diagnosed with lung cancer than among those not diagnosed with cancer (167). Here, CRP is linked to lung cancer.